World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
114
Citations
54279
World Ranking
4685
National Ranking
2544

Overview

Hans Lilja is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research predominantly focuses on the field of Medicine, with extensive work related to Pulmonary and Respiratory Medicine, Genetics, Cancer Research, Molecular Biology, and Oncology.

The scientist's primary research topics include Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Genetic Associations and Epidemiology, Bladder and Urothelial Cancer Treatments, Radiopharmaceutical Chemistry and Applications, Cancer, Lipids, and Metabolism, as well as Statistical Methods in Clinical Trials.

Hans Lilja has contributed significantly to a number of recent papers, including:

  • A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study (2021, The Lancet Oncology)
  • Genetically adjusted PSA levels for prostate cancer screening (2023, Nature Medicine)
  • Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI (2024, JAMA)
  • Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years (2020, JAMA Network Open)
  • Two-Step Acoustophoresis Separation of Live Tumor Cells from Whole Blood (2021, Analytical Chemistry)

Frequent co-authors collaborating with Lilja include Andrew J. Vickers, Sigrid Carlsson, Robert J. Klein, Peter T. Scardino, and Christopher A. Haiman.

The scientist's work has been published in numerous venues, with a notable number of publications appearing in European Urology, The Prostate, The Journal of Urology, bioRxiv (Cold Spring Harbor Laboratory), and Cancer Epidemiology Biomarkers & Prevention.

Best Publications

  • Screening and Prostate-Cancer Mortality in a Randomized European Study

    Fritz H. Schröder;Jonas Hugosson;Monique J. Roobol;Stefano Ciatto

  • Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

    Fritz H Schröder;Jonas Hugosson;Monique J Roobol;Teuvo L J Tammela

  • Prostate-Cancer Mortality at 11 Years of Follow-up

    Fritz H. Schröder;Jonas Hugosson;Monique J. Roobol;Stefano Ciatto

  • Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin.

    H Lilja;A Christensson;U Dahlén;M T Matikainen

  • Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

    Jonas Hugosson;Sigrid Carlsson;Gunnar Aus;Svante Bergdahl

  • Prostate-specific antigen and prostate cancer: prediction, detection and monitoring

    Hans Lilja;David Ulmert;Andrew J Vickers

  • A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein.

    H Lilja

  • Differential exoprotease activities confer tumor-specific serum peptidome patterns

    Josep Villanueva;David R. Shaffer;John Philip;Carlos A. Chaparro

  • Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer.

    Anders christensson;Thomas Björk;Olle Nilsson;Ulrika Dahlén

  • Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors.

    Anders Christensson;Carl-Bertil Laurell;Hans Lilja

  • Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

    Daniel C. Danila;Glenn Heller;Gretchen A. Gignac;Rita Gonzalez-Espinoza

  • Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition

    Andrew James Stephenson;Michael W Kattan;James A. Eastham;Zohar A. Dotan

  • Prevention and early detection of prostate cancer

    Jack Cuzick;Mangesh A Thorat;Gerald L Andriole;Otis W Brawley;Otis W Brawley

  • Seminal Vesicle-Secreted Proteins and Their Reactions During Gelation and Liquefaction of Human Semen

    H. Lilja;J. Oldbring;G. Rannevik;C.-B. Laurell

  • National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers

    Catharine M. Sturgeon;Michael J. Duffy;Ulf Håkan Stenman;Hans Lilja

  • A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

    Jonas Hugosson;Monique J. Roobol;Marianne Månsson;Teuvo L.J. Tammela

  • Molecular cloning of human prostate specific antigen cDNA

    Åke Lundwall;Hans Lilja

  • MOLECULAR FORMS OF PROSTATE-SPECIFIC ANTIGEN AND THE HUMAN KALLIKREIN GENE FAMILY A NEW ERA

    Robert T. McCormack;Robert T. McCormack;T.J. Wang;T.J. Wang;Harry G. Rittenhouse;Harry G. Rittenhouse;Robert L. Wolfert;Robert L. Wolfert

  • Free, complexed and total serum prostate-specific antigen : the establishment of appropriate reference ranges for their concentrations and ratios

    Joseph E. Oesterling;Steven J. Jacobsen;George G. Klee;Kim Petterson

  • Prostate-specific antigen and prostate cancer: Prediction, detection and monitoring (Corrigendum) (Nature Reviews Cancer (2008) 8, (268-278))

    H Lilja;D Ulmert;A J Vickers

Frequent Co-Authors

Andrew J. Vickers
Andrew J. Vickers Memorial Sloan Kettering Cancer Center
Peter T. Scardino
Peter T. Scardino Memorial Sloan Kettering Cancer Center
Anders Bjartell
Anders Bjartell Lund University
Kim Pettersson
Kim Pettersson University of Turku
Thomas Laurell
Thomas Laurell Lund University
James A. Eastham
James A. Eastham Memorial Sloan Kettering Cancer Center
Åke Lundwall
Åke Lundwall Lund University
Hartwig Huland
Hartwig Huland Universität Hamburg
Howard I. Scher
Howard I. Scher Memorial Sloan Kettering Cancer Center
Caroline O. S. Savage
Caroline O. S. Savage Academy of Medical Sciences

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare but not sure if medical school is right for you? There are several online degree options that prepare students for rewarding careers in the medical and healthcare fields. Many professionals pursue a Master of Healthcare Administration for specialized roles in leadership and management. For those looking for the gold standard, the top online mha programs that are cahme accredited ensure quality and recognition in the industry.

Nursing remains a popular pathway. If you’re already an RN seeking advancement, rn to bsn online programs without clinicals offer flexible learning without the need for additional on-site training. For nurses aiming for the highest clinical or leadership credentials, you can fast-track your journey with dnp programs online, some of which are structured to be completed in less time than traditional pathways.

Worried about program intensity? Explore the easiest online dnp programs for accessible learning paths that still advance your nursing career. Whether you’re interested in administration, advanced practice, or research, these program options can help you build a vibrant healthcare career without taking the traditional medical school route.

Best Scientists Citing Hans Lilja

Trending Scientists

Recently Published Articles